Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised USD $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development of therapeutics that meaningfully extends human health span and eventually life span. A meaningful increase in lifespan in the already ageing world will have profound implications on all sectors of society, and in particular healthcare, education, insurance and leisure.
Hemel Hempstead
ageing, agetech, health

Articles about Juvenescence:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Juvenescence? We’re happy to assist you with our Startup Sourcing service.